Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed...
13 insider purchases on record · latest filing 2022-05-16.
Insiders have also filed 1,832 sale transactions at NTRA.